Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A.sub.2 receptor antagonist
US4857548A · kind A · utility
1Cited by
0References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 17, 1988 |
| Grant date | Aug 15, 1989 |
| Priority date | — |
| Expiry date | Nov 17, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for preventing or reducing platelet loss during extracorporeal circulation, such as during coronary artery bypass of graft surgery by administering a thromboxane A.sub.2 antagonist alone or with prostacyclin and/or a prostacyclin mimic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.